Bioventus (BVS) Receivables - Net (2020 - 2026)

Bioventus' Receivables - Net history runs 7 years deep, the most recent figure standing at $123.6 million for Q1 2026.

• Quarterly Receivables - Net rose 2.21% year-over-year to $123.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.6 million (up 2.21% YoY) and the FY2025 annual result came in at $128.3 million, up 0.71% from the prior year.
• Receivables - Net was $123.6 million for Q1 2026 at Bioventus, down from $128.3 million in the prior quarter.
• Across five years, Receivables - Net topped out at $148.3 million in Q3 2022 and bottomed at $117.9 million in Q3 2023.
• A 5-year average of $128.4 million and a median of $127.4 million in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2022 — Receivables - Net surged 45.36% — and 2023, when it declined 19.33%.
• Bioventus' Receivables - Net stood at $136.3 million in 2022, then fell by 6.81% to $127.0 million in 2023, then gained by 0.3% to $127.4 million in 2024, then gained by 0.71% to $128.3 million in 2025, then dropped by 3.68% to $123.6 million in 2026.
• Business Quant data shows BVS's Receivables - Net at $123.6 million in Q1 2026, $128.3 million in Q4 2025, and $130.4 million in Q3 2025.